Rebecca McKillican is McKesson Canada’s Chief Executive Officer (CEO). As CEO, Ms. McKillican is responsible for leading McKesson's portfolio of businesses in Canada including pharmaceutical distribution operations, McKesson Canada Specialty Health, McKesson's network of independent pharmacies comprised of I.D.A., Guardian, Remedy'sRx, The Medicine Shoppe, Uniprix, and Proxim, e-commerce retailer Well.ca, and Rexall Pharmacy Group.
She joined McKesson Canada in 2017, while she was the CEO of Well.ca. Most recently, Ms. McKillican was President, Retail Solutions at McKesson Canada. In this role, she oversaw the organization’s retail assets across the country.
Ms. McKillican previously worked for the New York City-based private equity firm Kohlberg, Kravis & Roberts (KKR) within the retail and consumer group. While at KKR, Ms. McKillican spent the majority of her time driving operational improvements across the firm’s portfolio companies. In addition, she has worked at McKinsey & Company, as a strategic consultant. Ms. McKillican is also a board member of the National Bank of Canada.
Ms. McKillican was recently named Canada’s 2021 New CEO of the Year by the Globe and Mail’s Report on Business, and was honored as one of the winners of the Top 40 Under 40 Canada Award in 2018.